News

A case report described a woman with endometrial cancer in India with an extremely rare blood group type, complicating blood transfusions.

Researchers developed and validated a retrospective method for accurately identifying cases of HDFN to better understand its epidemiology.

Early transcutaneous bilirubin screening helps identify newborns at risk for dangerous jaundice related to HDFN before symptoms worsen.

Modifying existing phototherapy procedures, introducing adjunct therapies and changing light sources may improve HDFN treatment.

Researchers reached a consensus on six recommendations regarding the management of alloimmunized pregnancies.

Some patients who received a blood-filtering treatment were able to wait until they were further along in their pregnancies to begin IUTs.

Many RhD-negative pregnant women lose detectable anti-D protection before delivery, which may leave a small window of risk for HDFN.

Researchers found phototherapy, a common treatment for HDFN, is associated with a slightly higher cancer risk.

Conflicting guidance on RhD immune globulin is giving way to clearer recommendations that may spare many patients unnecessary treatment.

Researchers used AI-enhanced methods to identify rare noncoding RhD variants that could affect the severity of HDFN.